Trial · NCT03326063
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Provocative Dose 2 (PD2) During Aspirin Challenge | Ifetroban | 121 | Standard Error 48 | mg | |
| Provocative Dose 2 (PD2) During Aspirin Challenge | Placebo | 142 | Standard Error 46 | mg | |
| Percentage Change From Baseline of FEV1 During Aspirin Challenge (Bronchoconstriction) | Ifetroban | -18.8 | Standard Deviation 3.6 | percentage change from baseline | |
| Percentage Change From Baseline of FEV1 During Aspirin Challenge (Bronchoconstriction) | Placebo | -8.4 | Standard Deviation 2.1 | percentage change from baseline | |
| Aspirin-induced Leukotriene E4 (LTE4) Levels | Ifetroban | 0.72 | Standard Deviation 0.30 | ng/mg creatinine | |
| Aspirin-induced Leukotriene E4 (LTE4) Levels | Placebo | 0.15 | Standard Deviation 0.10 | ng/mg creatinine | |
| Change in Chronic Disease Control by Measurement of Lung Function Through FEV1 | Ifetroban | -0.2 | Standard Deviation 1.3 | percent change from baseline | |
| Change in Chronic Disease Control by Measurement of Lung Function Through FEV1 | Placebo | -0.5 | Standard Deviation 1.2 | percent change from baseline | |
| Change in Chronic Disease by Measurement of Asthma Control Through Asthma Control Questionnaire (ACQ) Score | Ifetroban | 0.17 | Standard Deviation 0.16 | scores on a scale | |
| Change in Chronic Disease by Measurement of Asthma Control Through Asthma Control Questionnaire (ACQ) Score | Placebo | -0.03 | Standard Deviation 0.11 | scores on a scale | |
| Clinical Improvement of Chronic Disease - Sino-Nasal Outcome Test (SNOT-22) Score | Ifetroban | 1.5 | Standard Deviation 3.0 | scores on a scale | |
| Clinical Improvement of Chronic Disease - Sino-Nasal Outcome Test (SNOT-22) Score | Placebo | -2.0 | Standard Deviation 2.3 | scores on a scale | |
| Fractional Exhaled Nitric Oxide (FeNO) | Ifetroban | 7.9 | Standard Deviation 9.0 | parts per billion | |
| Fractional Exhaled Nitric Oxide (FeNO) | Placebo | -3.4 | Standard Deviation 3.0 | parts per billion |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03326063/results